FT Options LLC - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
FT Options LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$263,000
-3.7%
21,060
+8.7%
0.40%
-15.5%
Q2 2017$273,000
-66.1%
19,375
-53.3%
0.47%
-26.3%
Q3 2016$805,000
+310.7%
41,530
+50.4%
0.64%
+211.2%
Q1 2016$196,00027,6140.20%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders